tranexamic acid has been researched along with Genetic Predisposition in 3 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The non-mucosal bleeding phenotype in hemophilia A appears largely unaffected by fibrinolysis." | 1.48 | Abrogating fibrinolysis does not improve bleeding or rFVIIa/rFVIII treatment in a non-mucosal venous injury model in haemophilic rodents. ( Bojko, B; Flick, MJ; Goryńska, PZ; Goryński, K; Knudsen, T; Ley, CD; Olsen, LH; Stagaard, R, 2018) |
| "We aimed to study the subgroups of hereditary angioedema with FXII mutation (FXII-HAE), unknown genetic defect (U-HAE) and idiopathic non-histaminergic acquired angioedema (InH-AAE)." | 1.42 | Characterization of patients with angioedema without wheals: the importance of F12 gene screening. ( Bafunno, V; Barca, MP; Del Giacco, SR; Firinu, D; Manconi, PE; Margaglione, M; Santacroce, R; Vecchione, G, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stagaard, R | 1 |
| Flick, MJ | 1 |
| Bojko, B | 1 |
| Goryński, K | 1 |
| Goryńska, PZ | 1 |
| Ley, CD | 1 |
| Olsen, LH | 1 |
| Knudsen, T | 1 |
| Firinu, D | 1 |
| Bafunno, V | 1 |
| Vecchione, G | 1 |
| Barca, MP | 1 |
| Manconi, PE | 1 |
| Santacroce, R | 1 |
| Margaglione, M | 1 |
| Del Giacco, SR | 1 |
| Blavignac, J | 1 |
| Bunimov, N | 1 |
| Rivard, GE | 1 |
| Hayward, CP | 1 |
1 review available for tranexamic acid and Genetic Predisposition
| Article | Year |
|---|---|
Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment.
Topics: Antifibrinolytic Agents; Factor V Deficiency; Gene Duplication; Genetic Predisposition to Disease; H | 2011 |
2 other studies available for tranexamic acid and Genetic Predisposition
| Article | Year |
|---|---|
Abrogating fibrinolysis does not improve bleeding or rFVIIa/rFVIII treatment in a non-mucosal venous injury model in haemophilic rodents.
Topics: Animals; Antifibrinolytic Agents; Coagulants; Disease Models, Animal; Factor VIIa; Factor VIII; Fibr | 2018 |
Characterization of patients with angioedema without wheals: the importance of F12 gene screening.
Topics: Adolescent; Adult; Aged; Angioedema; Angioedemas, Hereditary; Antifibrinolytic Agents; Bradykinin; B | 2015 |